Long-term results of combined treatment of colorectal cancer patients with liver metastases
- Авторлар: Chernoglazova E.V1, Vyshinskaya G.V1, Sagaidak I.V1, Rotobelskaya L.E1, Abramov M.E1, Filonenko D.A1
-
Мекемелер:
- FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
- Шығарылым: № 8 (2017)
- Беттер: 42-47
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/289852
- ID: 289852
Дәйексөз келтіру
Ашық рұқсат
Рұқсат берілді
Аннотация
The results of univariate and multivariate analyzes for the detection of significant factors predicting the survival of colorectal cancer patients with liver metastases are presented. The following significantly significant factors of favorable prognosis were established: achievement of III-IV degrees therapeutic pathomorphosis; normalization of the cancer-embryonic antigen levels of after preoperative chemotherapy; the prevalence of metastatic liver damage within one lobe. A treatment algorithm that has made it possible to achieve high survival rates has been proposed.
Толық мәтін
Авторлар туралы
E. Chernoglazova
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
Email: ev-onco@mail.ru
PhD, Senior Researcher at Department of Chemotherapy and Combined Treatment of Malignant Tumors
G. Vyshinskaya
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
I. Sagaidak
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
L. Rotobelskaya
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
M. Abramov
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
D. Filonenko
FSBI “Russian Oncological Research Center m.a. N.N. Blokhin" of RMH
Әдебиет тізімі
- Каприн А.Д., Старинский В.В., Петрова Г.В. (ред.). Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). М., 2016. 250 с.
- Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer. 2015;136(5):E359-86.
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology: colon cancer. Available at: http://www.nccn.org. Accessed November 8, 2016.
- National Comprehensive Cancer Network. Clinical practice guidelines in oncology: rectal cancer. Available at: http://www.nccn.org. Accessed November 8, 2016.
- Ciliberto D., Prati U., Roveda L., Barbieri V., Staropoli N., Abbruzzese A., Caraglia M., Di Maio M., Flotta D., Tassone P., Tagliaferri P. Role of systemic chemotherapy in the management of resected or resectable colorectal liver metastases: a systematic review and metaanalysis of randomized controlled trials. Oncol. Rep. 2012;27(6):1849-56.
- Adam R., Delvart V., Pascal G., Valeanu A., Castaing D., Azoulay D., Giacchetti S., Paule B., Kunstlinger F., Ghémard O., Levi F., Bismuth H. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 2004;240:644-57.
- Delaunoit T., Alberts S.R., Sargent D.J., Green E., Goldberg R.M., Krook J., Fuchs C., Ramanathan R.K., Williamson S.K., Morton R.F., Findlay B.P Chemotherapy permits resection of metastatic colorectal cancer: Experience from intergroup N9741. Ann. Oncol. 2005;16(3):425-29.
- Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13(1):51-64.
- Schmoll H.J., Van Cutsem E., Stein A., Valentini V., Glimelius. B., Haustermans K., Nordlinger B., van de Velde C.J., Balmana J., Regula J., Nagtegaal I.D., Beets-Tan R.G., Arnold D., Ciardiello F., Hoff P., Kerr D., Köhne C.H., Labianca R., Price T., Scheithauer W., Sobrero A., Tabernero J., Aderka D., Barroso S., Bodoky G., Douillard J.Y., Ghazaly H.E., Gallardo J., Garin A., Glynne-Jones R., Jordan K., Meshcheryakov A., Papamichail D., Pfeiffer P., Souglakos I., Turhal S., Cervantes A. ESMO consensus guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making. Ann. Oncol. 2012;23(10):2479-516.
- Патютко Ю.И., Сагайдак И.В., Поляков А.Н., Подлужный Д.В., Черноглазова Е.В., Чистякова О.В., Чучуев Е.С., Гахраманов А.Д., Косырев В.Ю. Хирургическое и комбинированное лечение больных колоректальным раком с метастатическим поражением печени. Онкол. колопроктол. 2011;1:32-9.
- Tomlinson J.S., Jarnagin W.R., De Matteo R.P., Fong Y., Kornprat P., Gonen M., Kemeny N., Brennan M.F., Blumgart L.H., D'Angelica M. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 2007;25(29):4575-80.
- Tsai M.S., Su Y.H., Ho M.C. Clinico-pathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann. Surg. Oncol. 2007;14(2):786-94.
- Kanas G.P., Taylor A., Primrose J.N., Langeberg W.J., Kelsh M.A., Mowat F.S., Alexander D.D., Choti M.A., Poston G. Survival after liver resection in metastatic colorectal cancer: review and metaanalysis of prognostic factors. Clin. Epidemiol. 2012;4:283-301.
Қосымша файлдар
